Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rxo (RXO) Equity Average (2021 - 2025)

Rxo (RXO) has disclosed Equity Average for 4 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average fell 4.38% year-over-year to $1.6 billion, compared with a TTM value of $1.6 billion through Dec 2025, down 4.38%, and an annual FY2025 reading of $1.6 billion, up 42.93% over the prior year.
  • Equity Average was $1.6 billion for Q4 2025 at Rxo, down from $1.6 billion in the prior quarter.
  • Across five years, Equity Average topped out at $1.6 billion in Q4 2024 and bottomed at $580.5 million in Q2 2024.
  • Average Equity Average over 4 years is $1.1 billion, with a median of $1.1 billion recorded in 2022.
  • The sharpest move saw Equity Average tumbled 49.68% in 2023, then surged 175.68% in 2024.
  • Year by year, Equity Average stood at $865.5 million in 2022, then tumbled by 31.6% to $592.0 million in 2023, then skyrocketed by 175.68% to $1.6 billion in 2024, then dropped by 4.38% to $1.6 billion in 2025.
  • Business Quant data shows Equity Average for RXO at $1.6 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.